Business
Bristol Myers Squibb Evolves and Expands Standing in the Gaap To Advance More Equitable Care in Multiple Myeloma As Program Marks Ten Years
New survey, guided by patient advocacy input, seeks to elevate lived experience and community voice to better understand challenges in multiple myeloma care PRINCETON, NJ / ACCESS Newswire / April 1, 2026 /Originally published by Bristol Myers Squibb ...
About this update from Bristol-myers Squibb Company
[{"type":"text","content":"New survey, guided by patient advocacy input, seeks to elevate lived experience and community voice to better understand challenges in multiple myeloma care","length":156,"tagName":"p"},{"type":"text","content":"PRINCETON, NJ / ACCESS Newswire / April 1, 2026 / Originally published by Bristol Myers Squibb","length":94,"tagName":"p"},{"type":"text","content":"Bristol Myers Squibb (NYSE:BMY, "BMS"), a global leader in oncology, announced the evolution of Standing in the Gaap, a long-running program designed to help address persistent gaps in care for people living with multiple myeloma (MM) in medically underserved communities. Building on a decade of sustained commitment, BMS is reinforcing its focus on equitable access to multiple myeloma education, resources, and community-driven solutions by expanding the program to reach more patients and care partners.","length":517,"tagName":"p"},{"type":"text","content":"As a central element of the Standing in the Gaap evolution, BMS is launching one of the largest multiple myeloma surveys ever conducted in the United States. The survey is designed to help illuminate the factors behind gaps in care, capturing perspectives that are often described anecdotally but not consistently measured across the multiple myeloma care continuum. The survey will engage more than 1,000 people living with multiple myeloma, along with their caregivers and healthcare providers, including communities that experience persistent barriers to care. The survey was developed with input from leading patient advocacy organizations, including the International Myeloma Foundation (IMF), Multiple Myeloma Research Foundation (MMRF), HealthTree Foundation (HTF), Blood Cancer United (BCU), and Black Health Matters (BHM), to help ensure the approach reflects real‑world experience and community priorities. By centering voices from across the multiple myeloma community, this listening-led approach aims to surface daily real‑world challenges, reflect how care is experienced today, and highlight where additional support is needed most.","length":1147,"tagName":"p"},{"type":"text","content":""Even the most advanced treatments can fall short if patients aren't represented in research, can't access care or struggle to navigate the healthcare system," said Andrew Whitehead, Vice President and Head of Popu...